We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.
- Authors
Aurpibul, L; Puthanakit, T; Sirisanthana, T; Sirisanthana, V
- Abstract
In resource-limited countries, stavudine (d4T) is commonly used as part of the initial highly active antiretroviral therapy (HAART) regimen. Many patients who subsequently develop lipodystrophy switch from d4T to zidovudine (ZDV), a drug that can be myelotoxic. We aimed to study the spectrum and severity of haematological changes following this substitution.
- Publication
HIV medicine, 2008, Vol 9, Issue 5, p317
- ISSN
1464-2662
- Publication type
Journal Article
- DOI
10.1111/j.1468-1293.2008.00560.x